Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
Crossref DOI link: https://doi.org/10.1007/s10120-015-0503-2
Published Online: 2015-05-22
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Hyeong Su
Ryu, Min-Hee
Zang, Dae Young
Ryoo, Baek-Yeol
Yang, Dae Hyun
Cho, Ji Woong
Lim, Man Sup
Kim, Min-Jeong
Han, Boram
Choi, Dae Ro
Kim, Jung Han
Jung, Joo Young
Song, Hunho
Park, Choong Kee
Kang, Yoon-Koo
Text and Data Mining valid from 2015-05-22